Cargando...
Engineering Remotely Triggered Liposomes to Target Triple Negative Breast Cancer
Triple Negative Breast Cancer (TNBC) continues to present a challenge in the clinic, as there is still no approved targeted therapy. TNBC is the worst sub-type of breast cancer in terms of prognosis and exhibits a deficiency in estrogen, progesterone, and human epidermal growth factor 2 (HER2) recep...
Guardado en:
| Publicado en: | Oncomedicine |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5292187/ https://ncbi.nlm.nih.gov/pubmed/28174679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/oncm.17406 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|